HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tamotsu Kanzaki Selected Research

alpha-N-Acetylgalactosaminidase (N-Acetyl-alpha-D-Galactosaminidase)

1/2005Three dimensional structural studies of alpha-N-acetylgalactosaminidase (alpha-NAGA) in alpha-NAGA deficiency (Kanzaki disease): different gene mutations cause peculiar structural changes in alpha-NAGAs resulting in different substrate specificities and clinical phenotypes.
1/2004Structural and immunocytochemical studies on alpha-N-acetylgalactosaminidase deficiency (Schindler/Kanzaki disease).
7/2002Defects in degradation of blood group A and B glycosphingolipids in Schindler and Fabry diseases.
5/2002Immunoelectron microscopic analysis of lysosomal deposits in alpha-N-acetylgalactosaminidase deficiency with angiokeratoma corporis diffusum.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tamotsu Kanzaki Research Topics

Disease

7Fabry Disease (Fabry's Disease)
04/2019 - 05/2002
7Neoplasms (Cancer)
05/2010 - 05/2002
5Type I Schindler Disease
03/2005 - 05/2002
4Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
07/2019 - 02/2006
3Carcinoma (Carcinomatosis)
05/2010 - 08/2005
3Skin Diseases (Skin Disease)
06/2006 - 08/2003
3Pyoderma Gangrenosum
08/2005 - 08/2002
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2010 - 11/2007
2Neoplasm Metastasis (Metastasis)
11/2007 - 06/2002
2Inflammation (Inflammations)
10/2006 - 01/2006
2Psoriatic Arthritis
06/2006 - 02/2004
2Breast Neoplasms (Breast Cancer)
01/2006 - 09/2002
2Extramammary Paget Disease (Paget Disease, Extramammary)
08/2005 - 05/2002
2Ulcer
08/2005 - 05/2005
2Dermatitis
05/2005 - 01/2003
2Melanoma (Melanoma, Malignant)
02/2005 - 06/2002
2Skin Neoplasms (Skin Cancer)
07/2004 - 05/2002
2Lysosomal Storage Diseases (Lysosomal Storage Disease)
09/2003 - 05/2002
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
07/2019
1Lymphoma (Lymphomas)
11/2016
1Ichthyosis (Xeroderma)
08/2014
1Trichothiodystrophy Syndromes
08/2014
1Cataract (Cataracts)
08/2014
1Xeroderma Pigmentosum (Kaposi's Disease)
08/2014
1Lymphadenopathy
01/2012
1Mucopolysaccharidosis I (Hurler Syndrome)
09/2008
1Pressure Ulcer (Bedsore)
03/2008
1Warts (Wart)
11/2007
1Basal Cell Carcinoma (Rodent Ulcer)
11/2007
1Bowen's Disease (Disease, Bowen)
11/2007
1Seborrheic Keratosis
11/2007
1Keratoacanthoma
11/2007
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
10/2007
1Mucolipidoses (Sialidosis)
03/2007
1Erythropoietic Protoporphyria
09/2006
1Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis)
06/2006
1Erythema
02/2006
1Scabies (Sarcoptic Mange)
02/2006
1Granuloma
01/2006

Drug/Important Bio-Agent (IBA)

6EnzymesIBA
03/2007 - 01/2004
4Monoclonal AntibodiesIBA
03/2014 - 02/2005
4alpha-Galactosidase (Beano)IBA
01/2006 - 07/2002
4alpha-N-Acetylgalactosaminidase (N-Acetyl-alpha-D-Galactosaminidase)IBA
01/2005 - 05/2002
2mogamulizumabIBA
11/2016 - 03/2014
2DNA (Deoxyribonucleic Acid)IBA
08/2014 - 04/2003
2Thymidine PhosphorylaseIBA
05/2010 - 05/2002
2AntigensIBA
03/2008 - 01/2003
2GlycoconjugatesIBA
03/2007 - 01/2004
2Mannose (D-Mannose)IBA
03/2007 - 01/2006
2Estrogens (Estrogen)FDA Link
01/2006 - 01/2003
2Blood Group Antigens (Blood Groups)IBA
03/2005 - 07/2002
2GlycosphingolipidsIBA
03/2005 - 07/2002
2Immunoglobulin G (IgG)IBA
03/2004 - 01/2003
2Biological ProductsIBA
06/2003 - 05/2002
2MucinsIBA
07/2002 - 05/2002
1EtretinateFDA Link
07/2019
1RetinoidsIBA
07/2019
1Antiviral Agents (Antivirals)IBA
07/2019
1GlycolipidsIBA
04/2019
1GalactosidasesIBA
04/2019
1Nonsense Codon (Nonsense Mutation)IBA
08/2014
1Collodion (Nitrocellulose)IBA
08/2014
1Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2010
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
05/2010
1Complementary DNA (cDNA)IBA
05/2010
1Fluorouracil (Carac)FDA LinkGeneric
05/2010
1Iduronidase (alpha-L-Iduronidase)IBA
09/2008
1Etoposide (VP 16)FDA LinkGeneric
04/2008
1Ficusin (Psoralen)IBA
04/2008
1Interferon-gamma (Interferon, gamma)IBA
04/2008
1sobuzoxaneIBA
04/2008
1Tryptases (Tryptase)IBA
03/2008
1Chymases (Chymase)IBA
03/2008
1beta CateninIBA
11/2007
1Cadherins (E-Cadherin)IBA
11/2007
1DapsoneFDA Link
10/2007
1SugarsIBA
03/2007
1LectinsIBA
03/2007
1G(M2) Ganglioside (Ganglioside GM2)IBA
03/2007
1InterleukinsIBA
10/2006
1Prostaglandins EIBA
10/2006
1ProstaglandinsIBA
10/2006
1Heme (Haem)IBA
09/2006
1Ferrochelatase (Heme Synthetase)IBA
09/2006
1acetylcelluloseIBA
06/2006
1crotamiton (Eurax)FDA LinkGeneric
02/2006
1benzyl benzoate (Ansar)FDA Link
02/2006
1Ivermectin (Mectizan)FDA Link
02/2006
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2006
1agalsidase alfaIBA
01/2006
1mannose-6-phosphateIBA
01/2006
1agalsidase betaFDA Link
01/2006
1Acetates (Acetic Acid Esters)FDA Link
01/2006
1Pharmaceutical PreparationsIBA
01/2006

Therapy/Procedure

9Blood Component Removal (Apheresis)
06/2006 - 08/2002
6Therapeutics
07/2019 - 08/2003
3Enzyme Replacement Therapy
01/2006 - 09/2003
1Injections
01/2006
1Subcutaneous Injections
01/2006